Improvement in myocardial energetics and perfusion with Liraglutide in patients with type 2 diabetes- A randomised, single centre, open label, cross-over drug trial

Back

ESC Professional Premium Access

Improvement in myocardial energetics and perfusion with Liraglutide in patients with type 2 diabetes- A randomised, single centre, open label, cross-over drug trial

Session: Cardiomyopathies in myocardial disease

Topic: Imaging

Speaker: Doctor H. Procter (Leeds, GB)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Henry Procter

Leeds (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

7 more presentations in this session

Changes in standard of care (SOC) medication during long-term mavacamten treatment for obstructive hypertrophic cardiomyopathy (HCM): results from the EXPLORER cohort of MAVA-Long-Term Extension (LTE)

Speaker: Doctor N. Lakdawala (Boston, US)

Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up

Speaker: Doctor M. Schiavo (Bologna, IT)

Association between hospital volume, clinical events, resource utilization, and costs of septal myectomy and alcohol septal ablation procedures in US patients with hypertrophic cardiomyopathy

Speaker: Doctor E. Maksabedian Hernandez (Los Angeles, US)

Electrocardiographic evolution in Anderson-Fabry disease: a valuable tool to detect progressive cardiac involvement

Speaker: Doctor R. Baldassarre (Bologna, IT)

Ultrastructural myocardial changes in patients with severe aortic stenosis referred for surgical aortic valve replacement

Speaker: Doctor R. Reis Santos (Lisbon, PT)

Access the full session

Cardiomyopathies in myocardial disease

Speakers: Doctor H. Procter, Doctor N. Lakdawala, Doctor M. Schiavo, Doctor E. Maksabedian Hernandez, Doctor R. Baldassarre...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources